ACS Med Chem Lett on Twitter: "Check out the joint Special Issue "Women in Medicinal Chemistry" with @JMedChem out today that showcases the excellent work performed by women in the field: https://t.co/IBlTGX1hqt
ACS Nanotation - Nanomaterials for (Nano)medicine via ACS Medicinal Chemistry Letters Next generation nanomedicine will rely on innovative nanomaterials capable of unprecedented performance. Which ones are the most promising candidates for a
![ACS Medicinal Chemistry Letters' Early Career Board Most Influential Articles | Pomerantz Laboratory ACS Medicinal Chemistry Letters' Early Career Board Most Influential Articles | Pomerantz Laboratory](http://pomerantz.chem.umn.edu/sites/pomerantz.dl.umn.edu/files/styles/panopoly_image_full/public/acs_axial_2019.jpg?itok=99LU8-o9)
ACS Medicinal Chemistry Letters' Early Career Board Most Influential Articles | Pomerantz Laboratory
![ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based](https://pbs.twimg.com/media/FI--VCbXMAQrvvI.jpg)
ACS Publications Bio & Med Chem Content on Twitter: "The first 2022 ACS Medicinal Chemistry Letters issue is out today! The cover accompanies the article by Shcherbakov et al. who report bispidine-based
![Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. - ORGC Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. - ORGC](https://orgc.research.vub.be/sites/default/files/thumbnails/image/amclct.png)
Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. - ORGC
ACS Med Chem Lett on Twitter: "Our new issue is out with cover art depicting the mechanism of action of vorasidenib (AG-881), a dual inhibitor of mutant IDH1 and 2 for the
![An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters - X-MOL An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters - X-MOL](https://xpic.x-mol.com/20220204%2F10.1021_acsmedchemlett.1c00623.gif)
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters - X-MOL
![Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.,ACS Medicinal Chemistry Letters - X-MOL Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.,ACS Medicinal Chemistry Letters - X-MOL](https://xpic.x-mol.com/20200911%2F10.1021_acsmedchemlett.0c00313.gif)